[
    {
        "molecule_name": "131",
        "protein_target_name": "HRH-1",
        "binding_metric": "KD",
        "value": "4.07E−08",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "113",
        "protein_target_name": "HRH-2",
        "binding_metric": "KD",
        "value": "7.72E−08",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "127",
        "protein_target_name": "HRH-3",
        "binding_metric": "KD",
        "value": "9.72E−08",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "154",
        "protein_target_name": "HRH-4",
        "binding_metric": "KD",
        "value": "6.97E−08",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "156",
        "protein_target_name": "HRH-6",
        "binding_metric": "KD",
        "value": "No binding",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "155",
        "protein_target_name": "HRH-5",
        "binding_metric": "KD",
        "value": "No binding",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "177",
        "protein_target_name": "HRH-7",
        "binding_metric": "KD",
        "value": "1.62E−07",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "Fluorescein",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "1.96E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "Fluorescein",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "2.65E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "Fluorescein",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "7.81E−08",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "Fluorescein",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "4.94E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1185",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "5.33E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1185",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "7.31E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1185",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "6.61E−08",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1185",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "1.59E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1274",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "4.29E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1274",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "5.61E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1274",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "8.47E−08",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1274",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "1.24E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1325",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "5.35E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1325",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "6.90E−09",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1325",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "8.53E−08",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "1325",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "8.13E−10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "118",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "118",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "10−8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "127",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "127",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "10−8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "132",
        "protein_target_name": "B7H3",
        "binding_metric": "Affinity",
        "value": "10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "132",
        "protein_target_name": "CD3",
        "binding_metric": "Affinity",
        "value": "10−8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 10\nBispecificantibody\tCD3 VH involved\tBIAcore KD(M)\n131\tHRH-1\t4.07E−08\n113\tHRH-2\t7.72E−08\n127\tHRH-3\t9.72E−08\n154\tHRH-4\t6.97E−08\n156\tHRH-6\tNo binding\n155\tHRH-5\tNo binding\n177\tHRH-7\t1.62E−07\n\n\nTABLE 11\nAffinity (M)\nHuman\tMonkey\tHuman\tMonkey\nAntibody\tB7H3\tB7H3\tCD3\tCD3\nMGD009\t1.96E−09\t2.65E−09\t7.81E−08\t4.94E−09\n1185\t5.33E−09\t7.31E−09\t6.61E−08\t1.59E−09\n1274\t4.29E−09\t5.61E−09\t8.47E−08\t1.24E−09\n1325\t5.35E−09\t6.90E−09\t8.53E−08\t8.13E−10\n\n\nAmong the selected antibodies, the test antibodies 118, 127 and 132 have an affinity to human B7H3 and human CD3 at levels of 10−9 and 10−8M, respectively, which are comparable to those of MGD009."
    },
    {
        "molecule_name": "118",
        "protein_target_name": "A498",
        "binding_metric": "EC50",
        "value": "0.34",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "118",
        "protein_target_name": "U87",
        "binding_metric": "EC50",
        "value": "2.4",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "118",
        "protein_target_name": "Detroit562",
        "binding_metric": "EC50",
        "value": "14.5",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "118",
        "protein_target_name": "A498",
        "binding_metric": "EC50",
        "value": "0.34",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "127",
        "protein_target_name": "A498",
        "binding_metric": "EC50",
        "value": "2.46",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "132",
        "protein_target_name": "A498",
        "binding_metric": "EC50",
        "value": "2.94",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "118",
        "protein_target_name": "U87",
        "binding_metric": "EC50",
        "value": "2.46",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "127",
        "protein_target_name": "U87",
        "binding_metric": "EC50",
        "value": "8.26",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "132",
        "protein_target_name": "U87",
        "binding_metric": "EC50",
        "value": "11.96",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "118",
        "protein_target_name": "Detroit562",
        "binding_metric": "EC50",
        "value": "14.53",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "127",
        "protein_target_name": "Detroit562",
        "binding_metric": "EC50",
        "value": "15.82",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "132",
        "protein_target_name": "Detroit562",
        "binding_metric": "EC50",
        "value": "15.71",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "118",
        "protein_target_name": "A498",
        "binding_metric": "EC50",
        "value": ">300",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "127",
        "protein_target_name": "A498",
        "binding_metric": "EC50",
        "value": ">300",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "132",
        "protein_target_name": "A498",
        "binding_metric": "EC50",
        "value": ">300",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "118",
        "protein_target_name": "U87",
        "binding_metric": "EC50",
        "value": ">300",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "127",
        "protein_target_name": "U87",
        "binding_metric": "EC50",
        "value": ">300",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "132",
        "protein_target_name": "U87",
        "binding_metric": "EC50",
        "value": ">300",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "118",
        "protein_target_name": "Detroit562",
        "binding_metric": "EC50",
        "value": ">300",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "127",
        "protein_target_name": "Detroit562",
        "binding_metric": "EC50",
        "value": ">300",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    },
    {
        "molecule_name": "132",
        "protein_target_name": "Detroit562",
        "binding_metric": "EC50",
        "value": ">300",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nFor example, the 118 has EC50 of 0.34, 2.4 and 14.5 nM for A498, U87 and Detroit562, respectively.\n118    A498    high    0.34    65.9    2.46    67.5    2.94    66.4    >300    20.9\n127    A498    high    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n132    A498    high    2.94    66.4    8.26    69.5    11.96    67.6    >300    3.8\n118    U87    intermediate    2.46    67.5    8.26    69.5    11.96    67.6    >300    3.8\n127    U87    intermediate    8.26    69.5    15.82    67.5    15.71    67.6    >300    3.8\n132    U87    intermediate    11.96    67.6    15.82    67.5    15.71    67.6    >300    3.8\n118    Detroit562    low    14.53    39.2    15.82    67.5    15.71    67.6    >300    3.8\n127    Detroit562    low    15.82    67.5    15.82    67.5    15.71    67.6    >300    3.8\n132    Detroit562    low    15.71    67.6    15.82    67.5    15.71    67.6    >300    3.8"
    }
]